Lipotec Active Ingredients' new skin care ingredient targets blue light

By Simon Pitman contact

- Last updated on GMT

Lipotec Active Ingredients' new skin care ingredient targets blue light
Lipotec Active Ingredients has launched a new ingredient that specifically targets and provides protection against the various sources of blue light that are now known to damage the skin.

Called Lumicease blue ingredient, it has been derived through biotechnology from one of the most radiation-resistant microorganisms to provide a solution that activates opsins on the skin that promote adaptive responses that help prefer the skin for future exposure to light.

The ingredient is also said to protect and repair the skin from solar and artificial blue-light-induced damage, ultimately minimizing the main signs of photoaging.

Development team targeted harmful light

In developing the ingredient, the Lipotec team considered the fact that the main reason for the aging of the skin is UV radiation, which is impossible to escape and ultimately causes about 90% of the signs of skin aging.

Likewise, the development process also considered the fact that the sun emits other types of harmful lights, such as infrared and blue light, the latter being also emitted by electronic devices such as smart phones and computer screens.

To protect from these types of light the team focused on the fact that human skin adapts by developing biological mechanisms referred to as opsins that serve to increase the resistance to light. This acts as a sensory system for light, increasing alertness and protection in the dermis.

In vitro testing

Mimicking this process to from the basis of the Lumicease mechanism, the team found that in vitro, in addition to activating opsins, the ingredient helped induce the skin adaptive responses against light damage.

Likewise, the results showed that the ingredient also helped in the increase of cell survival and the improvement and protection of the extracellular matrix.

Clinical tests were conducted on a group of women applying a 2% dosage of Lumicease blue ingredient on half the face and a placebo on the other, while being exposed to both artificial blue light and summer sun.

The results showed that brown spots decreased by 11.7% and the amount of UV spots were reduced by 14.1%, suggesting a significant repair effect. Likewise, a reduction of 21.5% in wrinkle volume was observed over the 56-day treatment.

Considering the results of the trials, the Lipotec team says it is assured that the ingredient protects and repairs the skin from solar and artificial blue light, while helping to minimize the signs of both digital and photoaging.

Related news

Related products

show more

Pandemic Beauty Formulas for Download

Pandemic Beauty Formulas for Download

Tagra Biotechnologies | 18-May-2020 | Application Note

Tagra is internationally renowned as a leader in microencapsulation, having obtained over 14 patents created by a team of PhD experts in microparticulate...

TXVector™ for Age Spots, Sun Damage, and PIH

TXVector™ for Age Spots, Sun Damage, and PIH

Actera Ingredients | 15-May-2020 | Product Brochure

TXVector™ is a targeted treatment for the visible effects of inflammation and hyperpigmentation. Based on pharma strength tranexamate chemistry, it erases...



SABINSA: Innovating the Science of Cosmetics® | 11-May-2020 | Data Sheet

Sabinsa's pTeroWhite®, a patented, natural pterostilbene extract from the heartwood of the Indian Kino Tree (Pterocarpus marsupium), delivers impressive...

Related suppliers

Follow us


View more